Product Information
NAPROXEN SODIUM 275 MG TAB is a generic product labeled by ScieGen Pharmaceuticals, Inc., priced at $0.1979 per EA under NDC 50228043205. Its NADAC has been published 156 times since Sep 9, 2020.
FDA first approved this application on Oct 30, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
275 mg/1
Manufacturer
ScieGen Pharmaceuticals, Inc.NDC
50228043205
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NAPROXEN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA212199FDA Approved
10/30/2019
TE Code
AB
On Market Since
10/30/2019
Pharmacological Classes
Price Statistics
The NADAC for NAPROXEN SODIUM 275 MG TAB has been published 156 times since Sep 9, 2020, and over the history we have for it it has declined 68.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1979 per EA |
|---|---|
| All-time high | $0.6297 (Mar 10, 2021) |
| All-time low | $0.1217 (Sep 18, 2024) |
| 52-week high | $0.3382 |
| 52-week low | $0.1722 |
| Median price | $0.2169 |
| Average price | $0.2814 |
| Largest weekly change | -65.4% (Apr 17, 2024) |
| Weeks tracked | 156 |
| Tracking since | Sep 9, 2020 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ScieGen Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Naproxen Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NAPROXEN SODIUM 275 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for NAPROXEN SODIUM 275 MG TAB, manufactured by ScieGen Pharmaceuticals, Inc., is $0.1979 per EA (NDC 50228043205), effective Sep 30, 2026.
How has the price of NAPROXEN SODIUM 275 MG TAB changed over time?
Over the history we have for it, the NADAC for NAPROXEN SODIUM 275 MG TAB has declined 68.6%. It has been tracked across 156 weekly CMS publications since Sep 9, 2020.
What are the highest and lowest recorded NADAC prices for NAPROXEN SODIUM 275 MG TAB?
Since Sep 9, 2020, the NADAC for NAPROXEN SODIUM 275 MG TAB has ranged from a low of $0.1217 (Sep 18, 2024) to a high of $0.6297 (Mar 10, 2021), with a median of $0.2169 per EA.
Are there cheaper alternatives to NAPROXEN SODIUM 275 MG TAB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as NAPROXEN SODIUM 275 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures NAPROXEN SODIUM 275 MG TAB?
NAPROXEN SODIUM 275 MG TAB (NDC 50228043205) is labeled by ScieGen Pharmaceuticals, Inc., and CMS classifies it as a generic product.